Lifco AB (publ)
OM-LIFCO B
Company Overview
Lifco AB (publ) engages in the dental, demolition and tools, and systems solutions businesses in Sweden, Norway, Germany, rest of Europe, Asia, Australia, North America, and internationally. It is involved in the distribution of dental equipment, such as disinfectants, saliva ejectors, bite registration and dental impression materials, bonding agents, and other consumables, as well as develops and sells medical record systems. The company also operates dental laboratory. In addition, it develops, manufactures, and sells demolition robots, and crane and excavator attachments to construction and earthworks, snow clearing, demolition, pipe and cable laying, forestry work, scrap handling and railway works. Further, the company engages in the contract manufacturing of electronic components, stainless steel products, and galvanized products for use in the security and alarm, industrial applications, telecom and IT, food products, and pharmaceutical industries; and the waste handling and recycling of tires, wires, refrigerators, aluminum products, and electronics. Additionally, it offers vehicle racking systems for service vans; equipment for sawing and handling of sawn lumber, as well as pellet mills; cleaning and sealing of pipes, as well as electrical supplies, and LED-lighting and measuring instruments for the surveying and construction industries; and telecom equipment to fiber market and aluminum cabinets. The company was founded in 1946 and is based in Enköping, Sweden. Lifco AB (publ) is a subsidiary of Carl Bennet AB.
Name
Lifco AB (publ)
CEO
Mr. Per Waldemarson
Website
www.lifco.se
Sector
Industrial Conglomerates
Year Founded
1993
Profile
Market Cap
SEK 149.44B
EV
SEK 158.74B
Shares Out
454.22M
Revenue
SEK 25.02B
Employees
6,851
Margins
Gross
44.56%
EBITDA
24.49%
Operating
19.26%
Pre-Tax
17.25%
Net
12.89%
FCF
16.69%
Returns (5Yr Avg)
ROA
9.79%
ROTA
-28.41%
ROE
22.11%
ROCE
20.27%
ROIC
10.49%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
SEK 329
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
SEK 1,707M
Net Debt
SEK 9,173M
Debt/Equity
0.66
EBIT/Interest
9.54
Growth (CAGR)
Rev 3Yr
17.48%
Rev 5Yr
13.76%
Rev 10Yr
15.03%
Dil EPS 3Yr
15.93%
Dil EPS 5Yr
16.94%
Dil EPS 10Yr
24.1%
Rev Fwd 2Yr
7.82%
EBITDA Fwd 2Yr
8.04%
EPS Fwd 2Yr
11.32%
EPS LT Growth Est
8.9%
Dividends
Yield
—
Payout
29.54%
DPS
SEK 2.1
DPS Growth 3Yr
20.51%
DPS Growth 5Yr
17.95%
DPS Growth 10Yr
25.31%
DPS Growth Fwd 2Yr
3.51%